Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment
Jiarui Lv(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongbing Zhang(Hebei University of Economics and Business)
Cited by 4
Related Papers
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
|Journal of Clinical Investigation|2003|479
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR
|Journal of Clinical Investigation|2007|381
Reciprocal Activation Between PLK1 and Stat3 Contributes to Survival and Proliferation of Esophageal Cancer Cells
|Gastroenterology|2011|102
Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome
|Proceedings of the National Academy of Sciences|2014|63
Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis
|Journal of Biological Chemistry|2015|48